AIM
CLGN icon

ARK Investment Management’s CollPlant Biotechnologies CLGN Stock Holding History

ARK Investment Management’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-235,660
Closed -$2.19M – 272
2022
Q2 		$2.19M Buy
235,660
+7,003
+3% +$64.3K 0.01% 180
2022
Q1 		$2.57M Buy
228,657
+63,203
+38% +$695K 0.01% 192
2021
Q4 		$2.71M Sell
165,454
-25,836
-14% -$461K 0.01% 221
2021
Q3 		$3.23M Buy
+191,290
New +$3.44M 0.01% 229

Other funds holding CLGN

RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
IMOV
Investment Management of Virginia Richmond, Virginia $526M AUM 3.23% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BFEC
Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
SQA
Simon Quick Advisors Morristown, New Jersey $2.19B AUM 17.29% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

ARK Investment Management's CLGN Position: Q3 2022 in Review

ARK Investment Management sold out of CollPlant Biotechnologies (CLGN) in Q3 2022, closing a stake of 235,660 shares — an estimated $2.19M sold.

ARK Investment Management first reported a position in CLGN in Q3 2021 and held it in 4 quarters. The position peaked at $3.23M in Q3 2021. 21 funds tracked by Wall St. Rank hold CLGN as of Q3 2022.

  • ARK Investment Management reported no remaining CollPlant Biotechnologies position as of Q3 2022 after selling out during the quarter.
  • ARK Investment Management sold 235,660 CollPlant Biotechnologies shares in Q3 2022, an estimated $2.19M.
  • ARK Investment Management first reported a position in CollPlant Biotechnologies in Q3 2021 and held it in 4 quarters.
  • ARK Investment Management's CollPlant Biotechnologies position peaked at $3.23M in Q3 2021.
  • 21 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2022.

Based on ARK Investment Management's 13F filing for Q3 2022, filed 17 Oct 2022.